Insulin, fast-acting

INSULIN_FAST

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC A10AB0[4-6]

13344

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

11250

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

11250

diagram downward connector

Include endpoints None

11250

diagram downward connector
INSULIN_FAST

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 10922 4985 5937
Unadjusted prevalence (%) 3.54 2.87 4.40
Mean age at first event (years) 44.13 41.49 46.34

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.80 [3.76, 6.14] 5.7e-36 1309
15 years 0.02 3.03 [2.38, 3.87] 2.6e-19 697
5 years 0.01 5.59 [4.64, 6.75] 2.6e-72 450
1 year 0.00 1.99 [1.35, 2.93] 5.0e-4 31

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: INSULIN_FAST – Insulin, fast-acting
GWS hits:

Survival analyses between endpoints

Plot

before Insulin, fast-acting
after Insulin, fast-acting

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Insulin, fast-acting